Healthcare · Biotechnology
HLB Co., Ltd.
028300KRX₩40,000+₩300 (+0.76%)Market closed
Price Chart
Daily
Key facts
- Market Cap
- ₩5.33T
- P/E
- −23.8x
- P/B
- 12.55x
- ROE
- −44.3%
HLB Co., Ltd.
Healthcare · Biotechnology · FY 2025
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
- CEO
- 진양곤, 백윤기
- Employees
- 160
- Website
- hlbbio.co.kr
Company Statistics
Valuation
P/E
−23.8x
P/B
12.55x
P/S
62.37x
EV/EBITDA
−28.8x
P/FCF
−47.7x
Margins
Gross
32.9%
EBITDA
−229.7%
Operating
−117.2%
Pre-Tax
−285.8%
Net
−279.7%
Returns
ROA
−25.9%
ROE
−44.3%
ROIC
−25.1%
Growth (CAGR)
Rev 3Yr
−22.3%
Rev 5Yr
8.4%
Op Inc 3Yr
—
Net Inc 3Yr
—
Financial Health
Cash & Cash Equivalents
₩40.98B
Net Debt
₩394.78B
Debt/Equity
88.1%
Interest Cov
—
Profile
Revenue
₩84.17B
Shares Out
133.2M